查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1457069

益生菌营养补充食品- 2024 年至 2029 年预测

Probiotics Dietary Supplements Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

益生菌营养补充食品预计将从2022年的64.82亿美元成长到2029年的97.95亿美元，复合年增长率为6.08%。

益生菌营养补充中发现的活有益细菌食品肠道菌丛的健康平衡，并支持免疫和消化器官系统活动。益生菌营养补充食品多种形式，包括胶囊、优格和发酵食品，经常服用来改善肠道健康。由于消费者对预防性保健的兴趣日益浓厚，人们对肠道健康对整体健康影响的认识不断提高，以及证明益生菌潜在益处的研究和开发不断增加，益生菌越来越受欢迎。由于抗生素的使用、消化器官系统健康问题的普遍存在以及向机能性食品的转变，益生菌营养补充的销售量食品增加。

健康意识的提高正在推动益生菌营养补充食品的发展。

营养补充食品在很大程度上是由于人们对肠道健康和消化系统疾病的了解不断增加而形成的。随着人们越来越意识到健康的肠道菌丛与整体健康之间的复杂关係，对益生菌锭剂的需求正在增加。知识的增长不仅鼓励了一系列专门针对消化器官系统健康的产品的创造和促销，而且使人们能够对自己的健康做出更好的决定。泰国等国家的旅游业正在成长，许多游客前往泰国旅游。这导致旅行者腹泻增加，这是从开发中国家到发展中国家的旅行者的常见健康问题。根据旅游和体育部的资料，2022年访问泰国的外国游客人数为8,824,049人次。预计到 2023 年，这一数字将进一步增加至 24,838,066，对预测期内的益生菌营养补充食品产生正面影响。

此外，益生菌营养补充越来越食品越来越多的糖尿病患者的欢迎，这可能是因为它们有助于控制血糖值并促进代谢健康。因此，益生菌营养补充食品预计将成长并影响客户的偏好。根据美国国家医学图书馆的数据，预计到 2020 年，30 岁及以上的韩国人中将有 16.7% 患有糖尿病。 2019-2020年，65.8%的糖尿病患者了解自己的病情并正在接受降血糖药物治疗。糖尿病在韩国成年人中仍然非常流行。 2019-2020年，只有9.7%的糖尿病患者血糖、血压、血脂得到完美控制。我们需要不断评估该国的糖尿病资料，并发起全国性宣传活动，以提高糖尿病意识并加强全面的糖尿病护理。

北美益生菌营养补充食品预计将稳定成长。

益生菌营养补充食品您的身体免受大肠激躁症、腹泻和乳糖不耐受感染疾病等肠道问题的影响。美国发炎性肠道疾病疾病的盛行率不断上升，预计将显着推动食品国对益生菌营养补充的需求，并促进整体市场成长。根据美国胃肠病学会（AGA）统计，大约有6000万至7000万美国患有胃肠道疾病，到2021年，近40%的人口将因令人不快的肠道活动暂停而患上日常疾病。胃肠道疾病在老年人中发病率很高，且在美国呈现显着成长趋势。根据世界银行预测，到2022年，17%的美国人口将超过65岁。而且，各种产品的推出以及在美国益生菌生产工厂的建立，正在进一步支持这些营养补充的市场成长。例如，2022年9月，皇家帝斯曼的「鼠李糖乳桿菌19070-2」和「罗伊氏乳桿菌12246-CU」益生菌菌株获得FDA核准，使该公司能够在美国市场提供肠道食品营养补充方案。同样，2019 年 7 月，杜邦公司在纽约开设了一家最先进的发酵工厂，生产用于食品和饮料、饮料和营养补充的高品质益生菌。

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 调查过程

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章益生菌营养补充食品：依菌株类型

  • 介绍
  • 乳酸菌
  • 双歧桿菌
  • 其他的

第六章益生菌营养补充食品：依健康细分市场

  • 介绍
  • 肠道健康
  • 整体健康
  • 免疫
  • 精神健康
  • 其他的

第七章益生菌食品营养补充市场：依销售管道分类

  • 介绍
  • 超级市场/大卖场
  • 药局
  • 在线的
  • 其他的

第八章益生菌营养补充食品：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第十章 公司简介

  • DuPont Inc.
  • Chr. Hansen Holding A/S
  • Probi（Symrise AG）
  • Lifeway Foods, Inc.
  • Kibow Biotech
  • Pharmavite LLC（Otsuka Pharmaceutical）
  • DSM
  • BioGaia
  • UniqueBiotech
  • Projoy Probiotic
简介目录
Product Code: KSI061611142

The probiotics dietary supplements market is expected to grow at a CAGR of 6.08% from US$6.482 billion in 2022 to US$9.795 billion by 2029.

Live beneficial bacteria included in probiotics dietary supplements help maintain a healthy balance of gut microflora, which supports immunological and digestive system activities. They may be obtained in a variety of forms, including capsules, yoghurts, and fermented meals, and are frequently taken to improve gut health. Probiotics dietary supplements are gaining popularity due to rising consumer interest in preventative healthcare, growing awareness of the influence of gut health on overall well-being, and increasing research and development demonstrating the potential advantages of probiotics. Probiotic supplement sales are also rising as a result of the growing prevalence of antibiotic use, digestive health problems, and a shift toward functional foods.

Increasing health awareness propels the probiotics dietary supplements market.

The dietary supplements market is being significantly shaped by the rise in knowledge of gut health and digestive disorders. Probiotic pills are in high demand as people become more aware of the complex relationship between a healthy gut microbiota and overall well-being. This increased knowledge not only encourages the creation and promotion of a wide range of goods aimed only at digestive health but also gives people the ability to make better decisions regarding their health. The growing tourism sector in countries like Thailand is leading to a large number of tourists visiting the country. This is leading to rising cases of traveler's diarrhea which is a common health problem among visitors from developed to developing countries. As per the data from the Ministry of Tourism and Sports in Thailand, the number of foreign tourists travelling to Thailand was 88,24,049 in 2022. This number further increased in 2023 to 2,48,38,066 which is anticipated to have a positive impact on the probiotics dietary supplements market during the forecast period.

Furthermore, probiotics dietary supplements are becoming more popular as diabetes rates rise, possibly because of their ability to help control blood sugar levels and enhance metabolic health. Owing to this, the market for probiotic supplements is anticipated to grow and influence customer preferences. As per the National Library of Medicine, in 2020, 16.7% of Korean people thirty years of age or older were predicted to have diabetes mellitus. 65.8% of people with diabetes mellitus from 2019 to 2020 were aware of their condition and received treatment with antidiabetic drugs. Among adult Koreans, diabetes mellitus remained highly prevalent. From 2019 to 2020, only 9.7% of persons with diabetes mellitus were able to maintain perfect glycemic, blood pressure, and lipid management. It is necessary to continuously assess the country's diabetes data and launch a nationwide campaign to raise awareness of diabetes mellitus and enhance all-encompassing diabetes treatment.

It is projected that the probiotics dietary supplements market in the North American region will grow steadily.

Probiotics dietary supplements prevent a body from bowel problems such as irritable bowel syndrome, diarrhoea, and lactose intolerance infections among others. The growing prevalence of inflammatory bowel disease in the United States is anticipated to majorly drive the demand for probiotics dietary supplements in the country, thereby augmenting the overall market growth. According to the American Gastroenterological Association (AGA), about 60-70 million Americans are suffering from gastrointestinal diseases, and in 2021, nearly 40% of the population stopped routine activities due to uncomfortable bowel symptoms. Digestive diseases have a high prevalence rate in older people, which is also witnessing significant growth in the US. According to the World Bank, in 2022, 17% of the US population aged 65 years and above. Additionally, various product launches and establishments of probiotics production plants in the United States have further propelled the market growth for such supplements. For instance, in September 2022, Royal DSM's "Lactobacillus rhamnosus 19070-2" and "Lactobacillus reuteri 12246-CU" probiotics strain were approved by the FDA which enabled the company to strengthen its gut health solutions offerings in the US market and explore more innovations in dietary supplement category. Likewise, in July 2019, DuPont opened its state-of-the-art fermentation plant in New York to produce high-quality probiotics for food & beverage and dietary supplements.

Market Key Developments

  • March 2023: Roquette a world leader in plant-based ingredients and a top supplier of pharmaceutical and nutraceutical excipients invited the health and nutrition industry to explore a more flexible, reliable, and consumer-focused future for probiotic supplements, introduced the PEARLITOL(R) ProTec. This solution is a novel plant-based co-processed combination of mannitol and maize starch, that stabilizes and extends the shelf life of active substances that are sensitive to moisture, such as probiotics. It also opens up new possibilities for consumer-friendly dose formulations.

Segmentation:

By Strain Type:

  • Lactobacillus
  • Bifidobacterium
  • Others

By Health Area:

  • Gut Health
  • General Health
  • Immunity
  • Mental Well-Being
  • Others

By Sales Channel:

  • Supermarket/Hypermarket
  • Pharmacy
  • Online
  • Others

By Geography

  • North America

By Strain Type

By Health Area

By Sales Channel

By Country

  • United States
  • Canada
  • Mexico
  • South America

By Strain Type

By Health Area

By Sales Channel

By Country

  • Brazil
  • Argentina
  • Others
  • Europe

By Strain Type

By Health Area

By Sales Channel

By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa

By Strain Type

By Health Area

By Sales Channel

By Country

  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific

By Strain Type

By Health Area

By Sales Channel

By Country

  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Australia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY STRAIN TYPE

  • 5.1. Introduction
  • 5.2. Lactobacillus
  • 5.3. Bifidobacterium
  • 5.4. Others

6. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY HEALTH AREA

  • 6.1. Introduction
  • 6.2. Gut Health
  • 6.3. General Health
  • 6.4. Immunity
  • 6.5. Mental Well-Being
  • 6.6. Others

7. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY SALES CHANNEL

  • 7.1. Introduction
  • 7.2. Supermarket/Hypermarket
  • 7.3. Pharmacy
  • 7.4. Online
  • 7.5. Others

8. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Strain Type
    • 8.2.2. By Health Area
    • 8.2.3. By Sales Channel
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Strain Type
    • 8.3.2. By Health Area
    • 8.3.3. By Sales Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Strain Type
    • 8.4.2. By Health Area
    • 8.4.3. By Sales Channel
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Strain Type
    • 8.5.2. By Health Area
    • 8.5.3. By Sales Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Strain Type
    • 8.6.2. By Health Area
    • 8.6.3. By Sales Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Australia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. DuPont Inc.
  • 10.2. Chr. Hansen Holding A/S
  • 10.3. Probi (Symrise AG)
  • 10.4. Lifeway Foods, Inc.
  • 10.5. Kibow Biotech
  • 10.6. Pharmavite LLC (Otsuka Pharmaceutical)
  • 10.7. DSM
  • 10.8. BioGaia
  • 10.9. UniqueBiotech
  • 10.10. Projoy Probiotic